nausea
Instructed in possible adverse reactions to Lanoxin including, anorexia, nausea, vomiting, diarrhea, yellow-green halos around visual images, fatigue, headache, and generalized muscle weakness.
Instructed in possible adverse reactions to Lopressor, including fatigue, lethargy, dizziness, low heart rate, low blood pressure, nausea, vomiting, diarrhea, rash, and fever.
Instructed in possible adverse reactions to Persantine, including diarrhea headache, weakness, flushing, dizziness, drop in B/P, nausea, vomiting, and skin rash. Instructed to take with meals if GI distress occurs and to watch for signs of bleeding.
Instructed in possible adverse reactions to Procardia, including dizziness, flushing, light headedness, headache, nausea, weakness, heartburn, and diarrhea.
Instructed in the possible side effects of NTG, including headache, dizziness with position changes, weakness, flushing, palpitations, fainting, nausea and vomiting. Notify MD should any side effects occur.
Instructed in possible adverse reactions of oral diabetic agents, which include nausea, vomiting, epigastric fullness, heartburn, hypoglycemia, rash, itching and facial flushing.
Instructed in S/S of hyperglycemia, such as excessive urination, thirst, nausea, vomiting, abdominal pain, or cramping, weak-tired feeling, drowsiness, deep-rapid breathing, or fruity breath. If these S/S occur client S/O instructed to notify MD.
Instructed patient on new medication Ciprofloxacin HCL, which is used to manage tract infection. In addition, warned of possible S/E, such as, headache, restlessness, tremor, dizziness, fatigue, drowsiness, insomnia, depression, light-headedness, confusion, hallucinations, seizures, paresthesia, thrombophlebitis, edema, nausea, diarrhea, vomiting, abdominal pain or discomfort, oral candidiasis, pseudomembranous colitis, dyspepsia, flatulence, constipation, crystalluria, interstitial nephritis, eosinophilia, leukopenia, neutropenia, thrombocytopenia, arthralgia, arthropathy, joint or back pain, joint inflammation, joint stiffness, tendon rupture, aching, neck or chest pain, rash, photosensitivity, Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis, burning, pruritus, erythema, hyperpigmentation.
Instructed patient about new medication, Allopuriniol, and in S/E, such as drowsiness, fever, headache, nausea, vomiting, diarrhea, abdominal pain, gastritis, rash, alopecia and others.
Instructed patient on possible adverse reactions to oral diabetic agents, which include: nausea, vomiting, epigastric fullness, heartburn, hypoglycemia, rash, itching and facial flushing.